These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7900385)

  • 1. [Use of isoptin SR-240 in treatment of hypertension].
    Knypl K; Brym E; Wacławek-Maczkowska J
    Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isoptin-Retard 240 mg in the treatment of mild and moderate arterial hypertension].
    Arabidze GG; Rogoza AN; Dmitriev VV; Metelitsa TV; Domba GIu; Sitina VK
    Ter Arkh; 1993; 65(9):50-2. PubMed ID: 8303597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of arterial hypertension with verapamil.
    Wigler I; Peer G; Soferman G; Blum M; Aviram A
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):162-6. PubMed ID: 6715085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Isoptin SR on blood pressure, heart function and hypertrophy of left ventricle of hypertensive patients.
    Qian XX; Chen AH; Deng JY; Tang XM; Liu YF; Li ZL; Ou SB; Wu ZN; Wang KR
    Chin Med J (Engl); 1994 Apr; 107(4):260-4. PubMed ID: 8088192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
    Cedro K; Dłuzniewski M; Szpytma M
    Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard].
    Arabidze GG; Dmitriev VV; Rogoza AN
    Klin Med (Mosk); 1994; 72(5):27-30. PubMed ID: 7853810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
    J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isoptin SR-240 and SR-120 in ambulatory treatment of arterial hypertension].
    Radziszewski A; Surynt M; Kopeć M
    Przegl Lek; 1996; 53(3):166-7. PubMed ID: 8754374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative anti-hypertensive effectiveness and tolerance of drugs in patients with mild and moderate arterial hypertension].
    Nesterov IuI; Gol'dberg GA; Detkovskaia NA
    Klin Med (Mosk); 1999; 77(8):33-6. PubMed ID: 10560253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
    Sobenin IA; Andrianova IV; Fomchenkov IV; Gorchakova TV; Orekhov AN
    Hypertens Res; 2009 Jun; 32(6):433-7. PubMed ID: 19390538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison and synergy in the treatment of essential arterial hypertension].
    Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerrero MI; Flores Serrano AG; González Franco MF
    Arch Inst Cardiol Mex; 1993; 63(2):133-7. PubMed ID: 8503714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.